Synthesis, Characterization, and Biological Evaluation of Integrin αvβ3-Targeted PAMAM Dendrimers-Reference-Cited by-同舟云学术

Synthesis, Characterization, and Biological Evaluation of Integrin αvβ3-Targeted PAMAM Dendrimers

Published:2008-06-07 Issue:4 Volume:5 Page:527-539
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Boswell C. Andrew¹,Eck Peter K.¹,Regino Celeste A. S.¹,Bernardo Marcelino¹,Wong Karen J.¹,Milenic Diane E.¹,Choyke Peter L.¹,Brechbiel Martin W.¹

Affiliation:

1. Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1088, Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1088, and Imaging Physics, Laboratory Animal Sciences Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp800022a

Reference42 articles.

1. Dendrimers in drug research

2. Designing dendrimers for biological applications

3. Magnetic resonance imaging contrast agents: Theory and the role of dendrimers

4. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organic coordination nanoparticles for phototheranostics;Coordination Chemistry Reviews;2024-03

2. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme;Current Drug Metabolism;2022-08

3. Chelation of gadolinium with carbonized citric and folic acids;Optical Technologies for Biology and Medicine;2022-04-29

4. An update on nanoparticle usage in breast cancer imaging;Nano Select;2022-03-10

5. Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells;RSC Advances;2022